I am not sure that all of what Dolci was saying is bad. He...

I am not sure that all of what Dolci was saying is bad. He didn't say the SP wouldn't run on news. It will, if the news is good. But, there is a chance that the gap will fill prior to the news being delivered. To be honest, I really hope it does, as I don't want talk about a gap later when we under way. But when news does arrive, be that the Quarterly, ethics approval for OSA etc we should move on up. Remember we just got a stage one result for a two stage pre-clinical trial, and it wasn't even for the final product. Yes it was a good result, but I have not found any company that has run from a pre-clinical trial. This is why I have been saying we need to manage our expectations. If/when we get fast track from FDA you had better be sitting down with your seatbelt fastened. Good results from the Phase 2 OSA will be another kicker.

Remember a lot of people got into the stock at a high price before the close. Some will be selling at market as they stoploss out. They don't even know what the company was about, they just saw a price/volume breakout and jumped on. So a share price pull back this week could very well happen. And if it does pull back, that is not a bad thing. You weren't going to sell now anyway were you? But it is opportunity to throw a buy order in at the gap or a support and you might get lucky. But as E has said, don't get greedy, as its easy to miss by a pip, we have all been that person.

Keep your eye on the prize. The excitement is about to begin.

DYOR, IMO ETC ETC